Congenital CMV infection: Prevalence in newborns and the impact on hearing deficit

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 11-12, 2008, Pages 935-942

  Engman, Mona Lisa ^a   Malm, Gunilla ^a   Engström, Lotta ^a   Petersson, Karin ^a   Karltorp, Eva ^a   Fahnehjelm, Kristina Tear ^b   Uhlen, Inger ^a   Guthenberg, Claes ^a   Lewensohn Fuchs, Ilona ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CHILD DEATH; CHORIORETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; HEARING IMPAIRMENT; HIGH RISK PATIENT; HUMAN; INFANT; MALE; NEWBORN; NEWBORN SCREENING; OTOACOUSTIC EMISSION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SWEDEN; UNILATERAL HEARING LOSS; VIRUS PATHOGENESIS;

CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEARING LOSS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREVALENCE; SWEDEN;

EID: 57049104586     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540802308431     Document Type: Article

References (25)

1. Demmler, GJ. (1991) Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis, 13, pp. 315-329.
2. Kimberlin, DW, Lin, CY, Sanchez, PJ, Demmler, GJ, Dankner, W. Shelton, M. et al. (2003) Effect of gancyclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr, 143, pp. 16-25.
3. Fowler, KB, Dahle, AJ, Boppana, SB and Pass, RF. (1999) Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed?. J Pediatr, 135, pp. 60-64.
4. Grosse, SD, Ross, DS and Dollard, SC. (2008) Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: A quantitative assessment. J Clin Virol, 41, pp. 57-62.
5. Ahlfors, K., Ivarsson, SA and Harris, S. (1999) Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis, 31, pp. 443-457.
6. Jones, CA. (2003) Congenital cytomegalovirus infection. Curr Probl Pediatr Adolesc Health Care, 33, pp. 70-93.
7. Dollard, SC, Grosse, SD and Ross, DS. (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol, 17, pp. 355-363.
8. Kenneson, A. and Cannon, MJ. (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol, 17, pp. 253-276.
9. Malm, G. and Engman, ML. (2007) Congenital cytomegalovirus infections. Semin Fetal Neonatal Med, 12, pp. 154-159.
10. Coats, DK, Demmler, GJ, Paysse, EA, Du, LT and Libby, C. (2000) Ophthalmological findings in children with congenital cytomegalovirus infection. J Aapos, 4, pp. 110-116.
11. Stagno, S. (2001) Cytomegalovirus. Infectious Diseases of the Fetus & Newborn infant, pp. 389-424. W.B. Saunders, Philadelphia
12. Adler, SP, Nigro, G. and Pereira, L. (2007) Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Semin Perinatol, 31, pp. 10-18.
13. Fowler, KB, McCollister, FP, Dahle, AJ, Boppana, S., Britt, WJ and Pass, RF. (1997) Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr, 130, pp. 624-630.
14. Grillner, L. and Strangert, K. (1986) Restriction endonuclease analysis of cytomegalovirus DNA from strains isolated in day-care centres. Pediatr Infect Dis, 5, pp. 184-187.
15. Ross, DS, Dollard, SC, Victor, M., Sumartojo, E. and Cannon, MJ. (2006) The epidemiology and prevention of congenital cytomegalovirus infection and disease: Activities of the Centers for Disease Control and Prevention Workgroup. J Womens Health (Larchmt), 15, pp. 224-229.
16. Fischler, B., Rodensjo, P., Nemeth, A., Forsgren, M. and Lewensohn-Fuchs, I. (1999) Cytomegalovirus DNA detection on Guthrie cards in patients with neonatal cholestasis. Arch Dis Child Fetal Neonatal Ed, 80, pp. 130-134.
17. Barbi, M., Binda, S., Primache, V., Caroppo, S., Dido, P. Guidotti, P. et al. (2000) Cytomegalovirus DNA detection in Guthrie cards: A powerful tool for diagnosing congenital infection. J Clin Virol, 17, pp. 159-165.
18. Barbi, M., Binda, S. and Caroppo, S. (2006) Diagnosis of congenital CMV infection via dried blood spots. Rev Med Virol, 16, pp. 385-392.
19. Malm, G., Grondahl, EH and Lewensohn-Fuchs, I. (2000) Congenital cytomegalovirus infection: A retrospective diagnosis in a child with pachygyria. Pediatr Neurol, 22, pp. 407-408.
20. van der Knaap, MS, Vermeulen, G., Barkhof, F., Hart, AA, Loeber, JG and Weel, JF. (2004) Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection. Radiology, 230, pp. 529-536.
21. Yun, Z., Lewensohn-Fuchs, I., Ljungman, P., Ringholm, L., Jonsson, J. and Albert, J. (2003) A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients. J Virol Methods, 110, pp. 73-79.
22. Sundqvist, VA and Wahren, B. (1981) An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Methods, 2, pp. 301-312.
23. Arvin, AM, Fast, P., Myers, M., Plotkin, S. and Rabinovich, R. (2004) Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee. Clin Infect Dis, 39, pp. 233-239.
24. Nigro, G., Adler, SP, La Torre, R. and Best, AM. (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med, 353, pp. 1350-1362.
25. Magnuson, M. (2000) Infants with congenital deafness: On the importance of early sign language acquisition. Am Ann Deaf, 145, pp. 6-14.